What's New

OklahomaMAT Monthly Newsletter

The most recent three OklahomaMAT monthly Newsletters are available now, click HERE!

Medication First Model for Treating Opioid Use Disorder

Medication First programs get people with OUD maintenance medical treatment as quickly as possible and provide voluntary supportive services as needed. Check out this brief to learn more about Missouri’s Medication First program. [LINK]

Opioid Use Disorder: Challenges and Opportunities in Rural Communities

Addressing Opioid Use Disorder in rural communities comes with a myriad of challenges. This fact sheet describes some common challenges along with strategies used by federal and state agencies to enhance treatment capacity. [LINK]

Think SMART Oklahoma

In January 2018, the Community Action Network (CAN) launched Think SMART Oklahoma, a Public Education Plan to reduce prescription drug related harm and increase awareness of the opioid epidemic. SMART stands for Safe solutions, Medical education, Awareness, Reverse overdose, Transform policy. To learn more about how to make a positive change in your community againt the national opioid epidemic, click HERE!

It's still not too late to get waivered!

Step 1: Register with ASAM at here

Step 2: Take the MAT Online Waiver Course

Step 3: Complete your Notice of Intent (NOI) Form

Step 4: Forward your Certificate of Completion to SAMSHA

Have Questions? Contact ASAM at mgrant@asam.org


Welcome to the Oklahoma Medication-Assisted Treatment (MAT) Expansion Project. This project aims to expand access to MAT for persons with opioid use disorder (OUD) by training and supporting rural primary care practices in Oklahoma. Medication-Assisted Treatment is an evidence-based strategy for treating persons with OUD. MAT combines the use of medications with counseling and behavior therapies to provide a whole-patient approach to treatment.

About Oklahoma Rural MAT Expansion

The Problem

Prescription drug overdoses kill nearly two Oklahomans per day. In many rural Oklahoma counties, opioids account for more than half of drug overdose deaths. Oklahoma lacks access to treatment for OUD, particularly in rural areas where there are few primary care providers trained to identify and treat people who are opioid dependent. Many Oklahoma providers are concerned about the devastating effect on their patients and communities. However, many providers also feel overwhelmed at the prospect of offering treatment for OUD in their own practice.

Click here for more information about opioid addiction in Oklahoma.

What We Offer

We offer practical, hands-on assistance to you and your office team through training, case-based consultations with addiction specialists, and mentoring from experienced medication-assisted treatment providers. Primary care physicians, nurse practitioners and physician assistants can receive certification and appropriate waivers to treat and manage opioid dependent patients in the office setting. Practices will receive a stipend to facilitate data collection for a planned evaluation of the project.

Find out if your practice is eligible to participate.

Who is offering this program?

The American Institutes for Research (AIR) is leading this project in partnership with the state of Oklahoma, the ECHO Institute at the University of New Mexico Health Sciences Center, and the American Society of Addiction Medicine. This project is supported by grant R18HS025067 from the Agency for Healthcare Research and Quality, an agency of the U.S. Department of Health and Human Services.

Click here to learn more about partners.

Contact Us

Join Today! To complete our brief eligibility screening form, please visit

Want to learn more about the project? If you'd like to listen to a recording of our informational webinar, entitled "Medication-Assisted Treatment in Rural Oklahoma," please follow this link.Sign up for an informational webinar with the project team and our consulting physicians.

If you have any questions, please contact the AIR team at:
or, Phone: 866-236-4285

This project is supported by grant number R18HS025067 from the Agency for Healthcare Research and Quality, an agency of the U.S. Department of Health and Human Services. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.